文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

基于血清S1P、miR-155-5p和sST2构建脓毒症患者脓毒性休克列线图预测模型

[Construct a nomogram prediction model for septic shock in patients with sepsis based on serum sphingosine-1-phosphate, microRNA-155-5p and soluble suppression of tumorigenicity 2 protein].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论基于年龄、乳酸、PCT、SOFA、APACHE II、S1P、sST2和miR-155-5p的列线图可预测脓毒症患者发生脓毒性休克,训练集AUC 0.865,验证集AUC 0.841。

前瞻性观察研究纳入400例脓毒症患者,按7:3随机分为训练集和验证集,训练集脓毒性休克发生率33.6%,验证集36.7%。多因素Logistic回归筛选出年龄>65岁、乳酸升高、PCT升高、SOFA评分升高、APACHE II评分升高、S1P降低、sST2升高和miR-155-5p升高为独立影响因素,并据此构建列线图。模型在训练集AUC为0.865(95%CI 0.819-0.903),验证集AUC为0.841(95%CI 0.793-0.882),校准良好,具有较好临床净获益。该模型可为脓毒症患者发生脓毒性休克的临床决策提供参考。

要点

  • 训练集脓毒性休克发生率33.6%(94/280),验证集36.7%(44/120),两组基线特征无统计学差异(均P>0.05)。
  • 多因素回归显示年龄>65岁(OR=1.425,95%CI 1.050-1.935)、乳酸升高(OR=1.538,95%CI 1.023-2.312)、PCT升高(OR=1.624,95%CI 1.049-2.514)为独立影响因素(均P<0.05)。
  • SOFA评分升高(OR=1.674,95%CI 1.107-2.531)、APACHE II评分升高(OR=2.547,95%CI 1.460-4.440)亦为独立影响因素(均P<0.05)。
  • S1P降低(OR=0.615,95%CI 0.405-0.934)、sST2升高(OR=2.017,95%CI 1.270-3.203)、miR-155-5p升高(OR=1.628,95%CI 1.072-2.472)为独立影响因素(均P<0.05)。
  • 列线图模型训练集AUC 0.865(95%CI 0.819-0.903),验证集AUC 0.841(95%CI 0.793-0.882),校准曲线和决策曲线显示良好校准和临床净获益。

适用人群与场景

  • 2022年1月至2025年1月聊城市第二人民医院收治的脓毒症患者,共400例,按7:3随机分为训练集(280例)和验证集(120例)。

诊断标准与关键阈值

  • 原文未提及脓毒症和脓毒性休克的具体诊断标准。
  • 模型基于年龄>65岁、乳酸升高、PCT升高、SOFA评分升高、APACHE II评分升高、S1P降低、sST2升高和miR-155-5p升高构建列线图,但原文未给出各指标的具体阈值或界值。

处置流程与药物剂量

  • 原文未提及基于该模型的具体处置流程或药物剂量。

红旗征与不能漏的情况

  • 原文未提及红旗征或需要立刻处理的情况。

研究设计与关键结果

  • 前瞻性观察研究,纳入400例脓毒症患者,训练集280例中94例(33.6%)发生脓毒性休克,验证集120例中44例(36.7%)发生脓毒性休克。
  • 训练集中脓毒性休克组与脓毒症组比较:年龄>65岁比例60.6% vs. 45.2%,乳酸(mmol/L)1.84±0.31 vs. 1.72±0.25,PCT(μg/L)11.23±3.15 vs. 8.54±2.57,IL-6(ng/L)138.37±36.12 vs. 112.54±31.73,SOFA评分10.34±3.15 vs. 8.26±2.83,APACHE II评分26.43±6.32 vs. 23.57±5.29,sS
  • 多因素Logistic回归:年龄>65岁(OR=1.425,95%CI 1.050-1.935)、乳酸升高(OR=1.538,95%CI 1.023-2.312)、PCT升高(OR=1.624,95%CI 1.049-2.514)、SOFA评分升高(OR=1.674,95%CI 1.107-2.531)、APACHE II评分升高(OR=2.547,95%CI 1.460-4.440)、S1P降低(OR=0.615,95%CI 0.40
  • 列线图模型ROC曲线:训练集AUC 0.865(95%CI 0.819-0.903),验证集AUC 0.841(95%CI 0.793-0.882);校准曲线和决策曲线显示良好校准和临床净获益。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究(单中心)。
  • 局限:单中心研究,样本量400例,模型需外部验证;原文未提及证据等级或推荐强度。

对床旁实践的改变

  • 该模型可用于脓毒症患者发生脓毒性休克的风险评估,辅助临床决策,但需注意其基于单中心数据,尚未外部验证。
  • 原文未提及该模型是否改变现有救治流程或适用/不适用人群的具体建议。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To establish a nomogram prediction model for septic shock in patients with sepsis based on serum sphingosine-1-phosphate (S1P), microRNA-155-5p (miR-155-5p) and soluble suppression of tumorigenicity 2 protein (sST2), and evaluate its predictive value.

METHODS: A prospective observational study was conducted. A total of 400 patients with sepsis admitted to Liaocheng Second People's Hospital from January 2022 to January 2025 were enrolled. The patients were randomly divided into the training set and the validation set at a ratio of 7 : 3. General clinical data were collected. Arterial blood gas analysis, routine blood test, liver and renal function tests, and inflammatory indicators were measured upon admission. Enzyme linked immunosorbent assay was used to measure serum levels of S1P and sST2. Real-time fluorescence quantitative reverse transcription-polymerase chain reaction was applied to detect the expression of serum miR-155-5p. Disease severity and organ dysfunction were also assessed. Patients were divided into sepsis group and septic shock group according to the occurrence of septic shock. Multivariate Logistic regression analysis was performed to screen independent influencing factors for septic shock, and a nomogram prediction model was constructed. Bootstrap resampling, receiver operator characteristic curve (ROC curve), calibration curve and decision curve analysis were used to validate and evaluate the model.

RESULTS: A total of 400 patients with sepsis were enrolled. Septic shock developed in 94 (33.6%) of the 280 patients in the training set and 44 (36.7%) of the 120 patients in the validation set. There were no statistically significant differences in baseline clinical characteristics between the training set and the validation set (all P>0.05). In the training set, compared with the sepsis group, the septic shock group had a higher proportion of patients aged over 65 years (60.6% vs. 45.2%), and increased levels of lactic acid (mmol/L: 1.84±0.31 vs. 1.72±0.25), procalcitonin [PCT (μg/L): 11.23±3.15 vs. 8.54±2.57], interleukin-6 [IL-6 (ng/L): 138.37±36.12 vs. 112.54±31.73], Sequential Organ Failure Assessment (SOFA: 10.34±3.15 vs. 8.26±2.83), Acute Physiology and Chronic Health Evaluation II (APACHE II: 26.43±6.32 vs. 23.57±5.29), sST2 (μg/L: 615.73±117.85 vs. 473.68±84.37) and miR-155-5p (miR-155-5p/U6: 1.74±0.36 vs. 1.35±0.28), the level of S1P was significantly decreased (μg/L: 67.38±18.31 vs. 87.54±24.67), all differences were statistically significant (all P<0.05). Multivariate Logistic regression analysis indicated that age over 65 years old [odds ratio (OR)=1.425, 95% confidence interval (95%CI) was 1.050-1.935], elevated lactic acid (OR=1.538, 95%CI was 1.023-2.312), elevated PCT (OR=1.624, 95%CI was 1.049-2.514), higher SOFA score (OR=1.674, 95%CI was 1.107-2.531), higher APACHE II score (OR=2.547, 95%CI was 1.460-4.440), decreased S1P (OR=0.615, 95%CI was 0.405-0.934), elevated sST2 (OR=2.017, 95%CI was 1.270-3.203) and elevated miR-155-5p (OR=1.628, 95%CI was 1.072-2.472) were independent influencing factors for septic shock in sepsis patients (all P<0.05). A nomogram was established based on the above factors. ROC curve analysis showed that the area under the curve (AUC) was 0.865 (95%CI was 0.819-0.903) in the training set and 0.841 (95%CI was 0.793-0.882) in the validation set. The model presented good calibration, favourable net clinical benefit and acceptable threshold probability in both sets.

CONCLUSIONS: The nomogram prediction model established based on serum S1P, sST2 and miR-155-5p has good predictive performance for septic shock in patients with sepsis, which can provide a reference for clinical decision-making.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu L, Liu Y, Tian J, et al. [Construct a nomogram prediction model for septic shock in patients with sepsis based on serum sphingosine-1-phosphate, microRNA-155-5p and soluble suppression of tumorigenicity 2 protein]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693964. doi:10.3760/cma.j.cn121430-20260205-00074

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。